The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study Read more about The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Financial Difficulty in Patients With Blood Cancer Read more about Financial Difficulty in Patients With Blood Cancer
A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma Read more about A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma
Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS Read more about Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS
Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors Read more about Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML Read more about Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
Hu8F4 in Treating Patients With Advanced Hematologic Malignancies Read more about Hu8F4 in Treating Patients With Advanced Hematologic Malignancies
National Cancer Institute "Cancer Moonshot Biobank" Read more about National Cancer Institute "Cancer Moonshot Biobank"
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy Read more about A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib Read more about CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib